BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Lin H, Cheng W, Huang Z, Zhang W. Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases. J Agric Food Chem 2022;70:4839-59. [PMID: 35436113 DOI: 10.1021/acs.jafc.2c00744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Huang M, Liu R. Editorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants. Front Pharmacol 2022;13:1006750. [DOI: 10.3389/fphar.2022.1006750] [Reference Citation Analysis]
2 Cheng W, Li M, Zhang L, Zhou C, Yu S, Peng X, Zhang W, Zhang W. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. Front Pharmacol 2022;13:973116. [DOI: 10.3389/fphar.2022.973116] [Reference Citation Analysis]
3 Chen H, Huang J, Ko C, Sainaghi PP. Peach Kernel Extracts Inhibit Lipopolysaccharide-Induced Activation of HSC-T6 Hepatic Stellate Cells. International Journal of Clinical Practice 2022;2022:1-6. [DOI: 10.1155/2022/4869973] [Reference Citation Analysis]
4 Li Y, Nie JJ, Yang Y, Li J, Li J, Wu X, Liu X, Chen DF, Yang Z, Xu FJ, Yang Y. Redox-Unlockable Nanoparticle-Based MST1 Delivery System to Attenuate Hepatic Steatosis via the AMPK/SREBP-1c Signaling Axis. ACS Appl Mater Interfaces 2022. [PMID: 35858286 DOI: 10.1021/acsami.2c05889] [Reference Citation Analysis]
5 Tang Z, Li L, Xia Z. Exploring Anti-Nonalcoholic Fatty Liver Disease Mechanism of Gardeniae Fructus by Network Pharmacology, Molecular Docking, and Experiment Validation. ACS Omega. [DOI: 10.1021/acsomega.2c02629] [Reference Citation Analysis]